Market attention is focused on NeOnc Technologies Holdings due to positive clinical trial results and discussions regarding the path toward a registrational study.

The entities involved

• Nasdaq →

  American fully electronic stock exchange

  • TWFG, Inc. is listed on the Nasdaq stock exchange, and Royal Bank of Canada raised its price target for the company.07:27
  • QumulusAI shares were listed on the Nasdaq stock exchange on October 24, 2026.07:02
• FDA →
  • Chris Carr, Georgia Attorney General, seeks stricter state laws following FDA warnings about kratom.06:23
  • The FDA approved a Skyrizi regimen for Crohn's disease, based on an AFFIRM trial led by UNC.01:48

Related events

• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7
• Cardiff Oncology and Nerviano Medical Sciences are seeking FDA regulatory review for Phase 3 trials and managing a licensing dispute over onvansertib.Jun 30
• Arthur Caplan questioned the FDA regarding the status of clinical trials in 2006.Thu 21:26
• EyePoint Pharmaceuticals developed its LUCIA trial program in alignment with the FDA, with enrollment noted in Lugano.Jun 8
• FDA removed the clinical hold on Arbutus Biopharma Corporation's IND application, allowing potential clinical development.Thu 13:45